Sarcopenic obesity in adults: how common is it and what affects it
Part of Hormones & metabolism clinical trials.
This study looks at how common 'sarcopenic obesity' is — a condition where people with obesity also have low muscle mass. It checks how this condition affects health over time and may lead to better ways to help people with obesity maintain muscle and improve well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must be obese, with a BMI above 30.
- You must be a patient at the hospital's clinical nutrition department having a metabolic check-up (to assess your body's energy and nutrition needs).
- You must not have cancer or severe long-term illnesses such as kidney, breathing (respiratory), or liver failure.
- You must not have a disease that affects your muscles or nerves (neuromuscular disease).
- You must be able to walk (no total walking disability).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how muscle loss (sarcopenia) might affect side effects from cancer treatments. If you are starting a new cancer treatment, a CT scan before treatment can help doctors predict your risk of side effects.
This study looks at how common it is to have both COPD (a chronic lung disease) and sarcopenic obesity (loss of muscle with excess body fat). By joining, you'll help doctors understand this condition better and may get a full health check-up.
This study looks at the link between muscle loss (sarcopenia) and obesity in older adults. It aims to understand why some older people who are overweight or obese also lose muscle strength and function, and how this affects recovery after hip surgery.
This study tests a new tool to diagnose muscle loss in people with obesity. It may help doctors better identify and treat this condition.
This study compares how obesity impacts physical abilities and everyday activities in people over 65. Researchers will measure strength, movement, and how well people manage daily tasks to better understand obesity's effects on aging.
This trial tests a new care approach for older adults who have both excess body fat and muscle loss (sarcopenic obesity). The goal is to help improve muscle strength, physical function, and body composition.
Hear when a new Obesity and Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.